Insights, Delivered Daily.

Shaky foundations. Stocks slipped late in yesterday’s session after a medical blog questioned Moderna’s Phase-1 results, out just a day earlier. The sharp moves in stocks highlight investors’ desires for clarity on the future of the economy, though none exist… yet.

One and done. Stocks surged yesterday emboldened by the aggressive Fed and encouraging news on the vaccine front. Traders woke up to surging markets and news from a once-small biotech firm sent the indexes ablaze with hope.

Who’s buying? Stocks ended Friday’s session higher despite abysmal retail data. New technology sanctions threaten to derail last year’s trade cease-fire in the US-China trade war, a new unknown now added to an already formidable list. N O T E W O R T H Y Maybe not this month. My regular readers...

Silver linings. Stocks went on a wild ride yesterday pulling out of early losses closing in the green as investors bet on a brighter, eventual, future. Beaten down bank stocks got a lift yesterday, leading the rally.

Just a bucket of ice. Stocks sold off for a second straight session as traders began to fear that a recovery might take a bit longer than they originally hoped. Fed Chairman Jerome Powell raised a warning that the country’s economic outlook is highly uncertain, requiring more stimulus.

All over the map. Stocks slid yesterday as a steady stream of bad news caused bulls to lose their nerve. Selling accelerated into the close as many wondered if the prior week's optimism was a bit overdone.